Invention Grant
- Patent Title: Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells
-
Application No.: US14976818Application Date: 2015-12-21
-
Publication No.: US09597384B2Publication Date: 2017-03-21
- Inventor: Dolores Schendel , Rudolf Wank
- Applicant: Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Applicant Address: DE Neuherberg
- Assignee: Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Current Assignee: Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Current Assignee Address: DE Neuherberg
- Agency: Clark & Elbing LLP
- Priority: DE10112851 20010316
- Main IPC: A61K35/15
- IPC: A61K35/15 ; A61K35/28 ; A61K48/00 ; A61K39/00 ; C12N5/10 ; C12N5/078

Abstract:
The present invention relates to semi-allogeneic antigen-presenting cells into which proteins and/or peptides or RNA or DNA or cDNA, respectively, encoding said proteins and/or peptides which are overexpressed in tumor cells or which are derived from autologous tumor cells or different tumor cells or different tumor cell lines have been introduced. Furthermore the invention relates to methods for the generation of these semi-allogeneic antigen-presenting cells as well as to the use thereof in the treatment of tumor diseases.
Public/Granted literature
- US20160250308A1 SEMI-ALLOGENIC ANTI-TUMOUR VACCINE WITH HLA HAPLO-IDENTICAL ANTIGEN-PRESENTING CELLS Public/Granted day:2016-09-01
Information query
IPC分类: